F. Pons

449 citations
12 papers · 363 indexed · h-index 8

F. Pons

11 papers receiving 355 citations

Peers

F. Pons
Comparison fields: 5 of 90
  • Immunology and Allergy 41
  • Chemical Health and Safety 3
  • Cardiology and Cardiovascular Medicine 86
  • Physiology 76
  • Nephrology 17
Replace Shota Fujimoto with:
Shota Fujimoto Japan
Milka M. Montiel United States
А Николов Bulgaria
Eva Fernvik Sweden
Guanghua Zhai China
Yuko Yamagata Japan
Vanessa Louzier France
Yi‐Giien Tsai Taiwan
A Nowak Poland
F. Pons relative to Shota Fujimoto Japan Shota Fujimoto's profile →
Citations per field
00.5×11×
Shota Fujimoto · 1×
Citations per year

Countries citing papers authored by F. Pons

Since Specialization
Citations

This map shows the geographic impact of F. Pons's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by F. Pons with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites F. Pons more than expected).

Fields of papers citing papers by F. Pons

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by F. Pons. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by F. Pons. The network helps show where F. Pons may publish in the future.

Co-authorship network

The 25 scholars most cited alongside F. Pons, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with F. Pons Line = papers co-authored together F. Pons links everyone, so they are left out of the graph.

All Works

12 of 12 papers shown
#Work
1 20206
2 201614
3 201040
4 201056
5 20090
6 2008118
7 200617
8 200464
9 200225
10
[The bronchorelaxant effect of helicidine, a Helix pomatia extract, interferes with prostaglandin E2].
199913
11 19947
12 19773

About F. Pons

F. Pons is a scholar working on Health, Toxicology and Mutagenesis, Immunology and Allergy, Earth-Surface Processes, Speech and Hearing and Radiation, having authored 12 papers that have together received 363 indexed citations. Recurring topics across this work include Indoor Air Quality and Microbial Exposure (3 papers), Occupational exposure and asthma (3 papers), Cardiac pacing and defibrillation studies (2 papers), Heart Failure Treatment and Management (2 papers), Asthma and respiratory diseases (2 papers), Cardiovascular Function and Risk Factors (2 papers), Cancer Cells and Metastasis (1 paper) and Air Quality and Health Impacts (1 paper). The work is most often cited by research in Immunology and Allergy (41 citations), Chemical Health and Safety (3 citations), Cardiology and Cardiovascular Medicine (86 citations), Physiology (76 citations) and Nephrology (17 citations). F. Pons has collaborated with scholars based in France, Spain and Belgium. Frequent co-authors include F. de Blay, Nelly Frossard, Carine Delayre‐Orthez, Cristina Agustí, Guiomar Solanas, Montserrat Porta-de-la-Riva, David Casagolda, Josep Baulida, Sandra Peiró and Alberto Múñoz. Their work appears in journals such as Clinical & Experimental Allergy, Medical dosimetry, Revista Española de Cardiología (English Edition), Journal of Cell Science and Materials Today Advances.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026